At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 15 enrolled
Drug / intervention
Amiloride +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pharmacokinetics of Amiloride Nasal Spray in Healthy Volunteers
In Brief
A Early Phase 1 clinical trial evaluating Amiloride for Pharmacokinetics. Completed, enrolled 15 participants across 1 site.
Detailed Summary
This study is a single-center, open-label study of the plasma pharmacokinetics of amiloride nasal spray at three different doses in healthy volunteers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPharmacokinetics
CountriesUnited States
CollaboratorsCenter for Addiction and Mental Health
Timeline
Early Ph 1CompletedFinished
2020202120222023202420252026
First PostedNov 2019
Enrollment StartSep 2020
Primary CompletionAug 2022
Study CompletionMar 2023
TodayJul 2026
First PostedNov 29, 2019
Enrollment StartSep 28, 2020
Primary CompletionAug 30, 2022
Study CompletionMar 6, 2023
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 6.6 years ago
Interventions
Amiloridedrug
Amiloride Nasal Spray
Amiloridedrug
Amiloride Nasal Spray
Amiloridedrug
Amiloride Nasal Spray